Acurx Pharmaceuticals LLC (ACXP) stock has reached a new 52-week low, trading at $0.72, as the company faces a challenging market environment. According to InvestingPro data, analysts maintain price targets between $10-12, suggesting potential upside, while the company maintains a healthy cash position with more cash than debt on its balance sheet. This latest price point reflects a significant downturn from previous valuations, marking a stark contrast to the more buoyant periods in the company’s recent trading history. Over the past year, ACXP has seen its value decrease dramatically, with a 1-year change showing a decline of -83.67%. This substantial drop has concerned investors and analysts alike, as they watch closely to see how the company will respond to the pressures that have led to this low ebb in its stock price. InvestingPro analysis reveals the stock often moves independently of broader market trends, which could…
2
